- Home
- MSM vs CRNX Comparison
MSM vs CRNX Comparison
Compare MSM & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSM
- CRNX
- Stock Information
- Founded
- MSM 1941
- CRNX 2008
- Country
- MSM United States
- CRNX United States
- Employees
- MSM N/A
- CRNX N/A
- Industry
- MSM Industrial Machinery/Components
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- MSM Industrials
- CRNX Health Care
- Exchange
- MSM Nasdaq
- CRNX Nasdaq
- Market Cap
- MSM 4.7B
- CRNX 2.8B
- IPO Year
- MSM 1995
- CRNX 2018
- Fundamental
- Price
- MSM $90.70
- CRNX $31.75
- Analyst Decision
- MSM Hold
- CRNX Strong Buy
- Analyst Count
- MSM 5
- CRNX 8
- Target Price
- MSM $90.60
- CRNX $74.86
- AVG Volume (30 Days)
- MSM 803.8K
- CRNX 725.8K
- Earning Date
- MSM 07-01-2025
- CRNX 08-07-2025
- Dividend Yield
- MSM 3.75%
- CRNX N/A
- EPS Growth
- MSM N/A
- CRNX N/A
- EPS
- MSM 3.54
- CRNX N/A
- Revenue
- MSM $3,743,630,000.00
- CRNX $760,000.00
- Revenue This Year
- MSM N/A
- CRNX $402.02
- Revenue Next Year
- MSM $3.66
- CRNX $771.03
- P/E Ratio
- MSM $25.62
- CRNX N/A
- Revenue Growth
- MSM N/A
- CRNX N/A
- 52 Week Low
- MSM $68.10
- CRNX $24.10
- 52 Week High
- MSM $92.68
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- MSM 68.74
- CRNX 57.94
- Support Level
- MSM $89.14
- CRNX $28.98
- Resistance Level
- MSM $92.68
- CRNX $32.49
- Average True Range (ATR)
- MSM 2.19
- CRNX 1.24
- MACD
- MSM 0.51
- CRNX 0.30
- Stochastic Oscillator
- MSM 84.25
- CRNX 90.54
About MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.